摘要
目的:探讨脉血康胶囊对脑梗死阿司匹林抵抗(AR)患者血小板聚集率影响。方法:78例患者随机分为阿司匹林组、脉血康组,分别在治疗前和治疗后1月测定二组血小板聚集率。结果:脉血康组可使脑梗死合并AR患者血小板聚集率下降,治疗前后比较差异有统计学意义(P<0.01)。结论:脉血康胶囊对脑梗死合并AR患者有抗血小板聚集作用,可改善脑梗死患者的AR。
Objective To study the Mai Xuekang Capsule cerebral infarction in the aspirin resistance （AR） the rate of platelet aggregation. Patients met the inclusion criteria, 78 cases were randomly divided into the aspirin group, Mai Xuekang group; before treatment and after treatment withonemonth measured platelet aggregation rate. Results Mai Xuekang Kang group allows cerebral infarction with AR in patients with platelet aggregation rate before and after treatment difference was statistically significant （ P 〈 0 01 ）. Conclusion Mai Xuekang Capsule platelet aggregation of patients with cerebral infarction AR AR in patients with cerebral infarction can be improved to a certain extent.
出处
《内蒙古中医药》
2013年第10期48-50,共3页
Inner Mongolia Journal of Traditional Chinese Medicine
关键词
脑梗死
阿司匹林抵抗
脉血康胶囊
血小板聚集率
cerebral infarction
aspirin resistance
Mai Xuekang Capsule
platelet aggregation rate
